Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

286 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic and Predictive Value of Immunoscore in Stage III Colorectal Cancer: Pooled Analysis of Cases From the SCOT and IDEA-HORG Studies.
Domingo E, Kelly C, Hay J, Sansom O, Maka N, Oien K, Iveson T, Saunders M, Kerr R, Tomlinson I, Edwards J, Harkin A, Nowak M, Koelzer V, Easton A, Boukovinas I, Moustou E, Messaritakis I, Chondrozoumaki M, Karagianni M, Pagès F, Arnoux F, Lautard C, Lovera Y, Boquet I, Catteau A, Galon J; TransSCOT Consortium; Souglakos I, Church DN. Domingo E, et al. J Clin Oncol. 2024 Mar 14:JCO2301648. doi: 10.1200/JCO.23.01648. Online ahead of print. J Clin Oncol. 2024. PMID: 38484206
Tau aggregation following subcortical hemorrhage.
Jaeger E, Bischof GN, Onur OA, Schlamann M, Drzezga A. Jaeger E, et al. Eur J Nucl Med Mol Imaging. 2024 Mar 4. doi: 10.1007/s00259-024-06662-5. Online ahead of print. Eur J Nucl Med Mol Imaging. 2024. PMID: 38433149 No abstract available.
Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II-III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysis.
Frei AL, McGuigan A, Sinha RRAK, Jabbar F, Gneo L, Tomasevic T, Harkin A, Iveson T, Saunders MP, Oien KA, Maka N, Pezzella F, Campo L, Browne M, Glaire M, Kildal W, Danielsen HE, Hay J, Edwards J, Sansom O, Kelly C, Tomlinson I, Kerr R, Kerr D, Domingo E; TransSCOT consortium; Church DN, Koelzer VH. Frei AL, et al. Lancet Oncol. 2024 Feb;25(2):198-211. doi: 10.1016/S1470-2045(23)00560-0. Lancet Oncol. 2024. PMID: 38301689 Free article.
Treatment of agitation in terminally ill patients with intranasal midazolam versus subcutaneous midazolam: study protocol for a randomised controlled open-label monocentric trial (MinTU Study).
Hirschinger H, Jaeger E, Nittka S, Hetjens S, Lorenz C, Remi C, Saussele S, Hofmann WK, Gencer D, Boch T. Hirschinger H, et al. Among authors: jaeger e. BMC Palliat Care. 2024 Jan 3;23(1):8. doi: 10.1186/s12904-023-01330-1. BMC Palliat Care. 2024. PMID: 38172871 Free PMC article.
Tumor necrosis factor α promotes clonal dominance of KIT D816V+ cells in mastocytosis: role of survivin and impact on prognosis.
Greiner G, Witzeneder N, Klein K, Tangermann S, Kodajova P, Jaeger E, Ratzinger F, Gerner MC, Jawhar M, Baumgartner S, Fruehwirth K, Schmetterer KG, Zuber J, Gleixner KV, Mayerhofer M, Schwarzinger I, Simonitsch-Klupp I, Esterbauer H, Baer C, Walter W, Meggendorfer M, Strassl R, Haferlach T, Hartmann K, Kenner L, Sperr WR, Reiter A, Sexl V, Arock M, Valent P, Hoermann G. Greiner G, et al. Among authors: jaeger e. Blood. 2024 Mar 14;143(11):1006-1017. doi: 10.1182/blood.2023020515. Blood. 2024. PMID: 38142424
Genomic and epigenomic analysis of plasma cell-free DNA identifies stemness features associated with worse survival in AR -altered lethal prostate cancer.
Chauhan PS, Alahi I, Sinha S, Shiang AL, Mueller R, Webster J, Dang HX, Saha D, Greiner L, Yang B, Ni G, Ledet EM, Babbra RK, Feng W, Harris PK, Qaium F, Jaeger EB, Miller PJ, Caputo SA, Sartor O, Pachynski RK, Maher CA, Chaudhuri AA. Chauhan PS, et al. Among authors: jaeger eb. medRxiv [Preprint]. 2023 Dec 1:2023.12.01.23299215. doi: 10.1101/2023.12.01.23299215. medRxiv. 2023. PMID: 38077092 Free PMC article. Preprint.
286 results